InvestorsHub Logo
Followers 0
Posts 19
Boards Moderated 0
Alias Born 05/17/2020

Re: Py11 post# 29

Friday, 05/22/2020 11:28:23 PM

Friday, May 22, 2020 11:28:23 PM

Post# of 233
The share price is still very reasonable for someone to get into IPA, given the potential but window of opportunity is narrowing day by day. I am glad I was able to get into this company long time ago (2+ years). This COVID is obviously none of us dreamt about, who would have thought we would be in the middle of this pandemic. I was just happy with what they were doing as a CRO working with 60 percent of the 20 largest Pharma's. As tragic this is for people dying or suffering from the virus I am really happy that we are in the right sector at the right time. In a way it is good to know that this company has the potential to find the therapeutic cure. I believe there partnership with Janssens will hook them with J&J. J&J has significant funding coming from the US Government for the COVID vaccine. IPA will have everything researched and will just have to pass on the results to J&J for clinical trials and vaccine production.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPA News